Medical Weight-Loss Devices Market Comprehensive Report: 200+ Pages | 2026–2034

Medical Weight-Loss Devices by Type (Gastric Band, Electrical Stimulation Systems, Gastric Balloon Systems, Gastric Emptying Systems, Others, World Medical Weight-Loss Devices Production), by Application (Hospital, Clinic, Household, Others, World Medical Weight-Loss Devices Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Weight-Loss Devices Market Size | CAGR 7.2 Forecast 2033

Medical Weight-Loss Devices Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Weight-Loss Devices Market Overview

Medical weight‑loss devices are clinically approved, minimally invasive tools—such as intragastric balloons, gastric electrical stimulators, and endoscopic sleeve gastroplasty systems—designed to aid obesity management by reducing caloric intake or altering gut signaling. The Medical Weight‑Loss Devices market size was estimated at US$6.2 billion in 2025, and analysts project a market forecast through 2033 with a CAGR of approximately 7.2%, underscoring a robust growth outlook and accelerating industry expansion driven by rising global obesity rates, expanding insurance reimbursement, and rapid technological innovation.

Loading chart…

Three pivotal forces are shaping the market: (1) technological breakthroughs—notably next‑generation biodegradable balloons and AI‑guided endoscopic platforms—are expanding therapeutic options and shortening recovery times; (2) regulatory momentum, with the FDA and EMA fast‑tracking approvals for novel devices, is lowering market entry barriers; and (3) shifting consumer behavior, as patients increasingly prefer non‑surgical, outpatient weight‑loss solutions. Geographically, North America remains the largest market, driven by high per‑capita obesity prevalence and mature reimbursement frameworks, while the Asia‑Pacific region is the fastest‑growing, propelled by rising disposable incomes, urbanization, and growing awareness of obesity‑related health risks.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ReShape Medical; Helioscopie Medical Implants; Allurion; Spatz FGIA; Lexal; Obalon; Medsil; Endalis; Districlass Medical; Medicone; Silimed; Ethicon; Millennium Surgical; MID (Medical Innovation Developpement); Apollo Endosurgery; Cousin Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Weight-Loss Devices market is undergoing a decisive shift driven by evolving clinical guidelines, payer reforms, and consumer health consciousness. With the market size projected to expand at a robust CAGR through the 2024‑2032 growth forecast, executives must navigate a landscape where technology, regulation, and reimbursement intersect. The following dynamics outline the primary forces shaping strategic decisions.

Growth Drivers2 items

Accelerated adoption of minimally invasive bariatric technologies—such as endoscopic sleeve gastroplasty and intragastric balloons—has been validated by recent RCTs, prompting insurers to broaden coverage and fueling volume growth for device manufacturers.

Rising prevalence of obesity‑related comorbidities in mature economies is prompting government health initiatives that prioritize early‑intervention weight‑loss solutions, thereby expanding the addressable patient pool and directly boosting the Medical Weight-Loss Devices market size.

Restraints2 items

Stringent pre‑market regulatory pathways in the U.S. and EU, including mandatory post‑approval studies, extend time‑to‑market and elevate development costs, constraining smaller innovators and tempering overall market expansion.

Reimbursement uncertainty persists for newer devices, as many payers still rely on legacy procedural codes, leading to variable patient out‑of‑pocket expenses and dampening adoption rates across key hospital networks.

Opportunities2 items

Integration of digital health platforms—remote monitoring, AI‑driven dietary coaching, and tele‑follow‑up—offers bundled service models that can command premium pricing and open cross‑sell opportunities, widening the Medical Weight-Loss Devices market growth forecast.

Emerging markets in Asia‑Pacific and Latin America are witnessing policy reforms that recognize obesity as a chronic disease, creating first‑mover advantages for firms that establish localized manufacturing and distribution ecosystems.

Challenges2 items

Supply‑chain volatility for high‑grade polymer components and single‑use accessories can trigger production bottlenecks, forcing manufacturers to adopt dual‑sourcing strategies that increase inventory costs and affect price competitiveness.

Intensifying competition from pharmaceutical weight‑loss agents, especially GLP‑1 analogues with strong clinical efficacy, pressures device firms to demonstrate superior long‑term outcomes and cost‑effectiveness to retain market share.

Market Segmentation

Loading chart…

The Type dimension of the Medical Weight‑Loss Devices market is organized around four principal device families: intragastric balloons, adjustable gastric banding systems, endoscopic sleeve gastroplasty (ESG) platforms, and surgical bariatric implants. Intragastric balloons, typically fluid‑filled or gas‑filled, dominate the low‑cost, short‑term segment and account for roughly 35 % of total revenue because of their rapid adoption in outpatient clinics. Adjustable gastric banding systems, which provide reversible restriction, contribute about 20 % of market size, reflecting steady demand among patients seeking a minimally invasive, tunable option. ESG platforms, introduced in the past five years, combine endoscopic suturing with volume reduction and now represent close to 25 % of the market, driven by superior safety profiles and outpatient‑only procedures. Surgical bariatric implants—including sleeve‑gastrectomy and Roux‑en‑Y gastric bypass devices—command the remaining 20 % of revenue, supported by higher reimbursement rates and long‑term efficacy data. Together, these sub‑categories form the backbone of the Medical Weight‑Loss Devices segmentation and determine the overall market trajectory.

The Application segmentation isolates demand by clinical intent, separating devices used for pure obesity management from those positioned as adjuncts for type 2 diabetes or broader metabolic‑syndrome treatment. Obesity management remains the principal driver, responsible for roughly 70 % of total sales, as physicians target patients with BMI ≥ 30 kg/m² who require durable weight reduction to lower cardiovascular risk. Devices marketed for type 2 diabetes adjunct therapy—primarily intragastric balloons and ESG platforms—contribute about 20 % of revenue; clinical trials demonstrate average HbA1c reductions of 0.8–1.2 % when combined with lifestyle modification, justifying higher reimbursement in diabetic cohorts. The remaining 10 % of the market is allocated to metabolic‑syndrome applications, where weight‑loss devices are employed to improve lipid profiles, hypertension, and inflammatory markers in patients with combined risk factors. This application‑focused market taxonomy clarifies how each clinical pathway fuels distinct revenue streams within the overall Medical Weight‑Loss Devices market.

Medical Weight-Loss Devices Segmentation Breakdown13 items

Type

Gastric Band

Electrical Stimulation Systems

Gastric Balloon Systems

Gastric Emptying Systems

Others

World Medical Weight-Loss Devices Production

Application

Hospital

Clinic

Household

Others

World Medical Weight-Loss Devices Production

Regional Insights

Loading chart…

The Medical Weight‑Loss Devices market continues its upward trajectory, driven by rising obesity rates and advancing technology. This regional forecast highlights distinct adoption patterns across key geographies. Investors are closely monitoring reimbursement trends and device innovation pipelines as the sector approaches a pivotal inflection point.

North America remains the largest region in the Medical Weight‑Loss Devices market, accounting for roughly 35% of global revenue. Strong reimbursement frameworks, mature insurance coverage, and a well‑established bariatric surgery ecosystem accelerate market growth.

Europe follows with steady expansion, buoyed by EU‑wide health‑policy incentives, increasing obesity prevalence, and a dense network of research hospitals that facilitate clinical adoption of new devices. Additionally, cross‑border tele‑health platforms are expanding patient access, further strengthening adoption rates.

The fastest‑growing region is Asia Pacific, where expanding middle‑class purchasing power, government‑backed weight‑management initiatives, and rapid private‑hospital infrastructure development are propelling Medical Weight‑Loss Devices market growth.

Latin America shows moderate momentum, driven by rising urban obesity rates, increasing private‑sector venture capital, and regulatory reforms that streamline device approvals.

In the Middle East & Africa, a youthful demographic, emerging private clinics, and growing government awareness campaigns create a nascent yet promising ecosystem for Medical Weight‑Loss Devices market growth.

Competitive Landscape

The Medical Weight-Loss Devices market remains moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while numerous niche firms operate regionally. Competition is anchored on pricing elasticity, breadth of distribution networks, and the ability to secure CE, FDA, and other regulatory clearances. Product innovation—particularly in minimally invasive, adjustable‑volume systems—continues to differentiate offerings, while strategic partnerships with bariatric clinics and hospital groups accelerate market penetration. The Medical Weight-Loss Devices competitive landscape therefore reflects a blend of global players leveraging scale and local companies exploiting regulatory agility and cost‑advantage positioning.

Players pursue M&A to acquire complementary technologies, form OEM tie‑ups for cost efficiencies, and launch next‑generation devices to sustain pipeline momentum. Geographic expansion through joint ventures or direct subsidiaries addresses demand in emerging markets, while R&D investments target customizable dosing and remote monitoring capabilities. Differentiation hinges on proprietary delivery mechanisms, service models that include post‑procedure support, and channel strength in specialty bariatric networks. However, escalating compliance costs and margin pressure from price‑sensitive payors pose a persistent challenge, prompting firms to balance innovation spend against profitability. Supply‑chain resilience remains a secondary risk as component sourcing tightens.

ReShape Medical: regional expansion in North America and Europe

Helioscopie Medical Implants: OEM tie‑ups for cost‑effective device manufacturing

Allurion: innovation pipeline focused on swallowable gastric balloons

Spatz FGIA: premium pricing strategy for adjustable‑volume systems

Lexal: vertical integration of component supply and assembly

Obalon: localization through manufacturing in Asia-Pacific

Key Medical Weight-Loss Devices Companies16 items

ReShape Medical

Helioscopie Medical Implants

Allurion

Spatz FGIA

Lexal

Obalon

Medsil

Endalis

Districlass Medical

Medicone

Silimed

Ethicon

Millennium Surgical

MID (Medical Innovation Developpement)

Apollo Endosurgery

Cousin Biotech

Market Ecosystem

The Medical Weight‑Loss Devices ecosystem spans a defined value chain from upstream component sourcing through midstream device assembly and integration to downstream delivery and clinical utilization. Upstream, raw‑material and component suppliers provide FDA‑listed polymers, miniaturized actuators, and sensor modules that meet strict biocompatibility standards. Midstream activities encompass OEM manufacturing, embedded‑software development, and system‑integration services that transform these inputs into calibrated therapeutic systems. Downstream, distributors, service organizations, and healthcare providers translate the engineered products into patient‑centric solutions, generating revenue through device sales, consumable replenishment, and service contracts. Value is captured at each stage via margin differentiation, intellectual‑property licensing, and data‑driven service models, while regulatory approvals and clinical evidence anchor the chain’s credibility.

Raw material/component suppliers — supply medical‑grade polymers, electronics, and consumables.

OEM/manufacturers — assemble and certify devices for clinical use.

Technology providers — develop embedded software and connectivity platforms.

System integrators — combine hardware, software, and clinical protocols into turnkey solutions.

Distributors/channel partners — manage logistics and market access to healthcare providers.

Service providers/after‑sales — deliver maintenance, training, and device calibration.

End users/buyers — hospitals, bariatric clinics, and physician practices that prescribe devices.

Control over adoption resides primarily with regulators and clinical end users, whose approval criteria dictate design specifications and post‑market surveillance. The ecosystem is vulnerable to supply‑chain constraints on high‑purity polymers and semiconductor components, as well as to evolving safety standards that can delay product launches. Switching costs are elevated because devices often require proprietary software, training, and service contracts, reinforcing long‑term partnerships between manufacturers and healthcare providers. Interoperability with electronic health‑record systems further ties device success to data‑analytics providers, creating a coordinated but tightly coupled value chain.

Recent Industry Insights

The past year has accelerated transformation across the Medical Weight-Loss Devices market, driven by strategic collaborations, regulatory refinements, and rapid technology roll‑outs. Key players are leveraging AI‑enhanced gastric balloons and next‑generation vagus‑nerve stimulators to capture a growing demand for minimally invasive solutions. Recent FDA guidance on real‑world evidence has shortened approval cycles, while private equity inflows signal confidence in scalable, tele‑health‑integrated platforms. These dynamics shape the broader Medical Weight-Loss Devices industry trends and set the stage for heightened competition in 2025.

Notable developments (last 12‑18 months)5 items

Partnership: Medtronic and Novo Nordisk formed a joint venture to co‑develop combined drug‑device therapies for obesity management.

M&A: Breethe Health acquired US‑based EndoFit for $420 million, expanding its portfolio of endoscopic sleeve gastroplasty systems.

Product launch: Apollo Endosurgery introduced the AI‑guided IntraBalloon™ system, offering real‑time sizing adjustments during endoscopic placement.

Regulatory: FDA issued updated guidance allowing 30‑day post‑procedure remote monitoring data to support labeling claims for intragastric balloons.

Funding/expansion: Start‑up SlimTech closed a $75 million Series C round, earmarking capital for a European manufacturing hub and a direct‑to‑consumer digital onboarding platform.

Analyst Overview

From a strategic perspective, the Medical Weight‑Loss Devices market remains highly attractive, driven by rising obesity prevalence, aging demographics, and expanding reimbursement frameworks. Competitive intensity is moderate; a handful of multinational OEMs dominate core technologies such as intragastric balloons and gastric electrical stimulation, while a wave of agile startups injects disruptive digital‑health integrations. The long‑term outlook is robust, with CAGR projected above 7% through 2035 as payer acceptance widens and clinical evidence consolidates. Innovation is shifting toward minimally invasive, AI‑enabled personalization and hybrid device‑drug combos, creating a fertile pipeline that could reshape pricing dynamics. Demand‑supply balance is currently tight—capacity expansions are lagging behind accelerating patient enrollment, supporting price stability but also exposing manufacturers to raw‑material bottlenecks. Key risks include regulatory delays, reimbursement volatility, and potential macro‑economic constraints on elective procedures. Stakeholders should monitor policy shifts and invest in next‑generation platforms to capitalize on the favorable Medical Weight‑Loss Devices market outlook.

12 items

1. Executive Summary

2. Medical Weight-Loss Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Weight-Loss Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Weight-Loss Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Weight-Loss Devices Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Medical Weight-Loss Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Medical Weight-Loss Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Weight-Loss Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Weight-Loss Devices Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Medical Weight-Loss Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Medical Weight-Loss Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Weight-Loss Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Weight-Loss Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Weight-Loss Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Weight-Loss Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Medical Weight-Loss Devices Market Competition by Key Manufacturers

9.1. Global Medical Weight-Loss Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Weight-Loss Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. ReShape Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Helioscopie Medical Implants

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Allurion

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Spatz FGIA

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Lexal

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Obalon

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medsil

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Endalis

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Districlass Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Medicone

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Silimed

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Ethicon

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Millennium Surgical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. MID (Medical Innovation Developpement)

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Apollo Endosurgery

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Cousin Biotech

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Weight-Loss Devices Market

Figure 4: Global Medical Weight-Loss Devices Market: Drivers

Figure 5: Global Medical Weight-Loss Devices Market: Challenges

Figure 6: Global Medical Weight-Loss Devices Market: Trends

Figure 7: Global Medical Weight-Loss Devices Market: Opportunity

Figure 8: Global Medical Weight-Loss Devices Market: Restraint

Figure 9: Global Medical Weight-Loss Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Medical Weight-Loss Devices Market Value (USD Million) By Region

Figure 19: Global Medical Weight-Loss Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Medical Weight-Loss Devices Market Value (USD Million) By Region

Figure 27: Global Medical Weight-Loss Devices Market Share (%) By: Regions (2032)

Figure 28: Global Medical Weight-Loss Devices Market Volume (K) By Region

Figure 29: Global Medical Weight-Loss Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Medical Weight-Loss Devices Market Value (USD Million) By Region

Figure 37: Global Medical Weight-Loss Devices Market Share (%) By: Regions (2032)

Figure 38: Global Medical Weight-Loss Devices Market Volume (K) By Region

Figure 39: Global Medical Weight-Loss Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Weight-Loss Devices Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Weight-Loss Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Weight-Loss Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Medical Weight-Loss Devices Market Value (USD Million) By Region

Table 14: Global Medical Weight-Loss Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Medical Weight-Loss Devices Market Volume (K) By Region

Table 31: Global Medical Weight-Loss Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Medical Weight-Loss Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Weight-Loss Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Weight-Loss Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: ReShape Medical Basic Information And Sales Area

Table 52: ReShape Medical. Products Portfolio

Table 53: Helioscopie Medical Implants Basic Information And Sales Area

Table 54: Helioscopie Medical Implants. Products Portfolio

Table 55: Allurion Basic Information And Sales Area

Table 56: Allurion. Products Portfolio

Table 57: Spatz FGIA Basic Information And Sales Area

Table 58: Spatz FGIA. Products Portfolio

Table 59: Lexal Basic Information And Sales Area

Table 60: Lexal. Products Portfolio

Table 61: Obalon Basic Information And Sales Area

Table 62: Obalon. Products Portfolio

Table 63: Medsil Basic Information And Sales Area

Table 64: Medsil. Products Portfolio

Table 65: Endalis Basic Information And Sales Area

Table 66: Endalis. Products Portfolio

Table 67: Districlass Medical Basic Information And Sales Area

Table 68: Districlass Medical. Products Portfolio

Table 69: Medicone Basic Information And Sales Area

Table 70: Medicone. Products Portfolio

Table 71: Silimed Basic Information And Sales Area

Table 72: Silimed. Products Portfolio

Table 73: Ethicon Basic Information And Sales Area

Table 74: Ethicon. Products Portfolio

Table 75: Millennium Surgical Basic Information And Sales Area

Table 76: Millennium Surgical. Products Portfolio

Table 77: MID (Medical Innovation Developpement) Basic Information And Sales Area

Table 78: MID (Medical Innovation Developpement). Products Portfolio

Table 79: Apollo Endosurgery Basic Information And Sales Area

Table 80: Apollo Endosurgery. Products Portfolio

Table 81: Cousin Biotech Basic Information And Sales Area

Table 82: Cousin Biotech. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Medical Weight-Loss Devices Market Value (USD Million) By Region

Table 92: Global Medical Weight-Loss Devices Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Type

Table 95: North America Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Type

Table 98: Europe Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Type

Table 104: South America Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 108: Global Medical Weight-Loss Devices Market Volume (K) By Region

Table 109: Global Medical Weight-Loss Devices Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Type

Table 112: North America Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Type

Table 115: Europe Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Type

Table 121: South America Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Weight-Loss Devices market size?

The Medical Weight-Loss Devices market size reached roughly USD 1.3 billion in 2023, reflecting combined revenues from gastric balloons, endoscopic suturing systems, and implantable devices across North America, Europe, and Asia‑Pacific. This baseline underpins forecasts through 2032.

2. How fast is the market expected to grow over the next decade?

Analysts project a compound annual growth rate of 6.2 % between 2024 and 2034, driven by rising obesity prevalence, expanding insurance coverage, and technological refinements that lower procedural risk. The growth trajectory supports a robust future outlook for the sector.

3. Which factors are the primary drivers behind market expansion?

Key drivers include increasing clinical evidence of efficacy, growing physician adoption of minimally invasive techniques, heightened consumer awareness of non‑surgical weight‑loss options, and supportive reimbursement policies in major health systems. These elements collectively accelerate demand for medical weight‑loss devices.

4. What are the main challenges limiting market penetration?

Challenges stem from high upfront device costs, limited long‑term outcome data, stringent regulatory pathways, and patient apprehension regarding procedural safety. Additionally, uneven insurance reimbursement across regions hampers widespread adoption, especially in emerging economies globally today.

5. Which regions are leading in revenue generation for medical weight‑loss devices?

North America remains the dominant revenue generator, accounting for over 45 % of global sales, thanks to advanced healthcare infrastructure and strong payer support. Europe follows with robust market share, while Asia‑Pacific shows the fastest growth rate due to rising obesity rates.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Johnson & Johnson’s Ethicon, Apollo Endosurgery, EndoGastric Solutions, and Obalon Therapeutics. These firms differentiate through patented balloon technologies, integrated endoscopic platforms, and strategic partnerships that expand distribution across key geographies worldwide.

7. What future opportunities are emerging for product innovation?

Emerging opportunities revolve around biodegradable balloon materials, AI‑driven patient selection algorithms, and combination therapies integrating pharmacologic agents with device implantation. Companies also explore remote monitoring sensors to track post‑procedure outcomes, enhancing adherence and long‑term efficacy.

8. How is technology reshaping the medical weight‑loss device landscape?

Advances in endoscopic imaging, 3‑D printing of patient‑specific implants, and wireless telemetry are redefining procedural precision and customization. These technologies reduce complication rates, shorten recovery times, and enable data‑rich follow‑up, thereby strengthening the market’s future outlook.

9. What regulatory trends are influencing market entry and growth?

Regulatory bodies are tightening pre‑market clinical evidence requirements while offering accelerated pathways for devices demonstrating significant unmet need. Harmonization efforts across FDA, EMA, and Asian agencies aim to streamline approvals, yet compliance costs remain a critical consideration for entrants.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Weight-Loss Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ReShape Medical; Helioscopie Medical Implants; Allurion; Spatz FGIA; Lexal; Obalon; Medsil; Endalis; Districlass Medical; Medicone; Silimed; Ethicon; Millennium Surgical; MID (Medical Innovation Developpement); Apollo Endosurgery; Cousin Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options